These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11896676)

  • 1. 32P-Postlabeling/polyacrylamide gel electrophoresis analysis: application to the detection of DNA adducts.
    Terashima I; Suzuki N; Shibutani S
    Chem Res Toxicol; 2002 Mar; 15(3):305-11. PubMed ID: 11896676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 32P-postlabeling DNA damage assays: PAGE, TLC, and HPLC.
    Shibutani S; Kim SY; Suzuki N
    Methods Mol Biol; 2006; 314():307-21. PubMed ID: 16673890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postlabeling/PAGE Method for Detection of DNA Adducts.
    Shiizaki K
    Methods Mol Biol; 2020; 2119():213-226. PubMed ID: 31989527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 32P-Postlabeling of N-(deoxyguanosin-8-yl)arylamine adducts: a comparative study of labeling efficiencies.
    Mourato LL; Beland FA; Marques MM
    Chem Res Toxicol; 1999 Jul; 12(7):661-9. PubMed ID: 10409407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen-DNA adduct formation in rat liver determined by immunoassay and 32P-postlabeling.
    Divi RL; Osborne MR; Hewer A; Phillips DH; Poirier MC
    Cancer Res; 1999 Oct; 59(19):4829-33. PubMed ID: 10519392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 32P-postlabeling and HPLC-FD analysis of DNA adducts in rats acutely exposed to benzo(a)pyrene.
    Godschalk RW; Vermeer IT; Kriek E; Floot B; Schilderman PA; Moonen EJ; Kleinjans JC; van Schooten FJ
    Chem Biol Interact; 1997 Apr; 104(1):41-54. PubMed ID: 9158694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 32P-postlabeling of bile components: bulky adduct-like behavior in polyethyleneimine-cellulose thin layer chromatography.
    Vulimiri SV; Smith CV; Randerath E; Randerath K
    Carcinogenesis; 1994 Sep; 15(9):2061-4. PubMed ID: 7923604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of tamoxifen--DNA adducts in leukocytes from breast cancer patients treated with tamoxifen.
    Umemoto A; Monden Y; Lin CX; Abdul-Momen M; Ueyama Y; Komaki K; Laxmi YR; Shibutani S
    Chem Res Toxicol; 2004 Dec; 17(12):1577-83. PubMed ID: 15606132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzo[a]pyrene-7,8-quinone-3'-mononucleotide adduct standards for 32P postlabeling analyses: detection of benzo[a]pyrene-7,8-quinone-calf thymus DNA adducts.
    Balu N; Padgett WT; Nelson GB; Lambert GR; Ross JA; Nesnow S
    Anal Biochem; 2006 Aug; 355(2):213-23. PubMed ID: 16797471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and quantification of tamoxifen-DNA adducts in the liver of rats and mice.
    Umemoto A; Komaki K; Monden Y; Suwa M; Kanno Y; Kitagawa M; Suzuki M; Lin CX; Ueyama Y; Momen MA; Ravindernath A; Shibutani S
    Chem Res Toxicol; 2001 Aug; 14(8):1006-13. PubMed ID: 11511174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrospray ionization-tandem mass spectrometry and 32P-postlabeling analyses of tamoxifen-DNA adducts in humans.
    Beland FA; Churchwell MI; Doerge DR; Parkin DR; Malejka-Giganti D; Hewer A; Phillips DH; Carmichael PL; Gamboa da Costa G; Marques MM
    J Natl Cancer Inst; 2004 Jul; 96(14):1099-104. PubMed ID: 15265972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative determination of aristolochic acid-derived DNA adducts in rats using 32P-postlabeling/polyacrylamide gel electrophoresis analysis.
    Dong H; Suzuki N; Torres MC; Bonala RR; Johnson F; Grollman AP; Shibutani S
    Drug Metab Dispos; 2006 Jul; 34(7):1122-7. PubMed ID: 16611860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity.
    Alexandrov K; Rojas M; Geneste O; Castegnaro M; Camus AM; Petruzzelli S; Giuntini C; Bartsch H
    Cancer Res; 1992 Nov; 52(22):6248-53. PubMed ID: 1423269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pH of the T4 polynucleotide kinase reaction on the 32P-postlabeling assay of DNA adducts.
    Lee CK; Brown BG; Bombick BR; Doolittle DJ
    Anal Biochem; 1995 May; 227(1):156-61. PubMed ID: 7668376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, characterization, and 32P-postlabeling of N-(deoxyguanosin)-4-aminobiphenyl 3'-phosphate adducts.
    Haack T; Boche G; Kliem C; Wiessler M; Albert D; Schmeiser HH
    Chem Res Toxicol; 2004 Jun; 17(6):776-84. PubMed ID: 15206898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of tamoxifen-DNA adducts in human endometrial explants exposed to alpha-hydroxytamoxifen.
    Kim SY; Suzuki N; Laxmi YR; McGarrigle BP; Olson JR; Sharma M; Sharma M; Shibutani S
    Chem Res Toxicol; 2005 May; 18(5):889-95. PubMed ID: 15892583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 32P-postlabeling assay for DNA adducts.
    Phillips DH; Arlt VM
    Nat Protoc; 2007; 2(11):2772-81. PubMed ID: 18007613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of oligodeoxynucleotides containing a diastereoisomer of alpha-(N(2)-2'-deoxyguanosinyl)tamoxifen by phosphoramidite chemical synthesis.
    Santosh Laxmi YR; Suzuki N; Dasaradhi L; Johnson F; Shibutani S
    Chem Res Toxicol; 2002 Feb; 15(2):218-25. PubMed ID: 11849048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of HPLC in the 32P-postlabeling assay.
    Gorelick NJ
    Mutat Res; 1993 Jul; 288(1):5-18. PubMed ID: 7686266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 32P-postlabeling analysis of DNA adducts.
    Phillips DH; Hewer A; Arlt VM
    Methods Mol Biol; 2005; 291():3-12. PubMed ID: 15502206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.